An in-house testing for detection of homologous recombination repair deficiency (HRD) in patients with solid tumors.
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe15025-e15025, 1p
- Subject
- Language
- ISSN
- 0732183X